| Metric | Current Period | Prior Year Same Period | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥403.2B | ¥330.7B | +21.9% |
| Operating Income / Operating Profit | ¥5.5B | ¥-62.2B | +98.2% |
| Ordinary Income | ¥11.7B | ¥-70.5B | -57.1% |
| Net Income attributable to owners of parent | ¥19.2B | ¥-44.5B | +143.2% |
| ROE | 4.1% | -9.3% | - |
FY2026 results: Revenue ¥403.2B (YoY +¥72.5B +21.9%), Operating Income ¥5.5B (YoY +¥67.7B +98.2%), Ordinary Income ¥11.7B (YoY +¥82.2B -57.1%), Net Income attributable to owners of parent ¥19.2B (YoY +¥63.7B +143.2%). The company turned from a large loss in the prior year to profit, but the operating margin remains low at 1.4%. The recovery in Ordinary Income and below relied heavily on exchange gains of ¥7.1B and special gains of ¥20.9B (including gain on sale of investment securities ¥2.1B); core operating profitability remains unfinished. Gross profit margin improved to 74.9% (prior year 67.0%) up 7.9pt, but SG&A of ¥296.3B (prior year ¥283.9B, 73.5% of sales) absorbed gains, making the operating-stage profit recovery fragile.
[Revenue] Revenue was ¥403.2B, a double-digit increase of +21.9% YoY. Segment disclosure is a single Pharmaceuticals segment, so details are limited, but an increase in trade receivables of ¥19.3B (+15.8%) suggests expanded sales to external customers. Cost of sales was ¥101.3B (prior year ¥109.0B), down -7.1%, and a decline in cost amid higher sales suggests improved production efficiency or favorable product mix. As a result, gross profit was ¥301.9B (YoY +¥80.0B +36.1%) and gross margin improved to 74.9% (+7.9pt).
[Profit & Loss] SG&A was ¥296.3B, up ¥12.4B (+4.4%) YoY, below the sales growth rate of +21.9%, indicating partial operating leverage. Operating Income turned positive to ¥5.5B from ¥-62.2B prior, with an operating margin of 1.4% (prior year -18.8%) improving by +20.2pt. Non-operating income totaled ¥14.5B including dividend income ¥0.4B and exchange gains ¥7.1B, while non-operating expenses of ¥8.4B included interest expense ¥4.0B and exchange losses ¥2.0B, resulting in Ordinary Income of ¥11.7B (prior year -¥70.5B). Special gains of ¥20.9B (including gain on sale of investment securities ¥2.1B) lifted profit before tax to ¥32.2B, and after deducting income taxes ¥10.2B, Net Income attributable to owners of parent was ¥19.2B, a substantial recovery from prior year -¥44.5B. In conclusion, while top- and bottom-line gains were achieved, operating-stage margins remain low and the recovery below Ordinary Income depended heavily on exchange gains and special gains, so sustainability requires attention.
[Profitability] Operating margin improved to 1.4% from -18.8% (+20.2pt) but remains low in absolute terms. Gross margin of 74.9% improved +7.9pt from 67.0%, implying favorable product mix, but a high SG&A ratio of 73.5% limits operating leverage. ROE was 4.1%, improving from -9.0%, but the structure is Net Margin 4.8% (prior year -13.5%) × Total Asset Turnover 0.37 × Financial Leverage 2.31, indicating low profitability and weak asset efficiency as constraints. ROA (based on Ordinary Income) was 1.1%, improving from -6.8%. [Cash Quality] Operating Cash Flow (OCF) was -¥1.4B, far below Net Income ¥19.2B (OCF/Net Income -0.07x), indicating extremely weak cash generation. The main drivers were working capital increases: trade receivables +¥19.3B and inventories +¥18.5B. EBITDA (Operating Income ¥5.5B + Depreciation ¥25.6B = ¥31.1B) to OCF conversion was -0.04x. Receivables days were 128 days (14,163/403.2×365), inventory days 76 days (2,117/(10,134/12)×365), and the cash conversion cycle has lengthened. [Investment Efficiency] Capex was ¥114.3B, 4.47x depreciation ¥25.6B, and Construction in Progress (CIP) reached ¥194.1B (17.8% of total assets), indicating large pre-operational investments underway. Free Cash Flow was -¥126.4B, funded by an increase in short-term borrowings of ¥150.9B. [Financial Soundness] Equity Ratio was 43.4%, down -1.7pt from 45.1%. Interest-bearing debt was short-term borrowings ¥380.9B + long-term borrowings ¥122.0B = ¥502.9B, up +30.9% from prior ¥384.1B. Debt/EBITDA was 16.2x, and interest coverage was 1.39x (Operating Income ¥5.5B / interest expense ¥4.0B), indicating weak interest-paying capacity. Current ratio was 116.5% (current assets ¥560.8B / current liabilities ¥481.4B), a minimal safety margin, but with cash ¥140.1B versus short-term borrowings ¥380.9B, maturity mismatch is significant.
OCF was -¥1.4B, improved from -¥54.9B prior but still negative. Starting from profit before tax ¥32.2B (prior year -¥59.8B), addbacks included depreciation ¥25.6B (prior year ¥33.7B), while working capital outflows—trade receivables increase ¥19.3B (prior was decrease ¥26.98B), inventories increase ¥18.5B (prior ¥12.5B), and accounts payable decrease ¥0.7B (prior ¥3.0B)—resulted in ¥39.2B of cash outflow, causing cash outflows far exceeding profit. Equity-method losses ¥1.8B, exchange loss/gain ¥4.0B, and income taxes paid ¥7.6B (prior year refund ¥22.8B) were also drags. OCF subtotal was -¥6.0B, and after non-cash adjustments such as gain on sale of investment securities ¥2.1B, OCF ended at -¥1.4B. Investing CF was -¥125.0B, mainly due to purchase of tangible fixed assets ¥114.3B. CIP rose to ¥194.1B as large pre-operational investments proceed, but cash returns have not yet materialized. Proceeds from sale of securities ¥16.7B partially offset outflows. Free Cash Flow was -¥126.4B, worsening from -¥103.6B prior. Financing CF saw a large inflow of ¥133.1B, mainly net increase in short-term borrowings ¥150.9B. Long-term borrowings net increased ¥7.0B (¥37.5B new borrowings and ¥30.5B repayments). Dividend payments ¥24.4B and share buybacks ¥25.3B totaled ¥49.7B returned to shareholders. As a result, cash increased by ¥8.1B to an ending balance of ¥140.1B. The structure of covering negative OCF and large investments with short-term borrowings indicates elevated liquidity risk until CIP comes online and working capital cycles normalize.
Of Ordinary Income ¥11.7B, non-operating income ¥14.5B was a material component, with exchange gains ¥7.1B (equivalent to 129% of Operating Income ¥5.5B) and gains on sale of investment securities included in non-operating income supporting operating-stage profitability. After deducting non-operating expenses including exchange losses ¥2.0B (total non-operating expenses ¥8.4B), the company maintained ordinary profitability, but exchange volatility introduces uncertainty in reproducibility. Special gains ¥20.9B (including gain on sale of investment securities ¥2.1B) accounted for 65% of profit before tax ¥32.2B, indicating limited recurring earning power. Comprehensive income was ¥19.9B, nearly matching Net Income ¥19.2B, with valuation difference on available-for-sale securities -¥5.0B, foreign currency translation adjustments ¥1.4B, and other comprehensive income attributable to affiliates ¥4.0B netting to a ¥0.7B positive contribution. From an accrual perspective, the large gap between OCF -¥1.4B and Net Income ¥19.2B, driven by trade receivables +¥19.3B and inventories +¥18.5B, substantially impairs earnings quality. Distinguishing ordinary vs one-off items, Operating Income ¥5.5B is the core of recurring earnings, but the sustainability of final Net Income ¥19.2B—supported by exchange gains ¥7.1B and special gains ¥20.9B—is limited; future exchange trends and improvement in operating margins are key.
Full-year guidance: Revenue ¥457.0B (YoY +13.3%), Operating Income ¥11.0B (YoY +98.2%), Ordinary Income ¥5.0B (YoY -57.1%), Net Income attributable to owners of parent ¥2.0B, Dividend ¥10. Progress against guidance: Revenue 88.2% (403.2/457.0), Operating Income 50.0% (5.5/11.0), Ordinary Income 233.0% (11.7/5.0), Net Income 960.0% (19.2/2.0). Using Q4 year-end normalized progress of 100%, Revenue and Operating Income are behind, indicating slower core business progress, whereas Ordinary and Net Income substantially exceeded expectations due to exchange gains and special gains that outperformed company assumptions. The shortfall in Operating Income is likely due to SG&A burden and CIP not yet operational; achieving SG&A absorption and CIP commissioning in H2 is key to meeting guidance. Ordinary Income beat guidance (actual ¥11.7B vs forecast ¥5.0B) mainly due to exchange gains and special gains, suggesting either conservatism in company guidance or an improved external environment. The forecast dividend ¥10 is half the actual dividend ¥20, and given the full-year Net Income forecast ¥2.0B (forecast EPS 1.64 yen), the payout ratio would be 610% on paper and therefore excessive, but aligns with a conservative stance reflecting weak cash generation and investment burden.
Dividends were interim ¥10 and year-end ¥10 for an annual ¥20 (prior year annual ¥10). The payout ratio against Net Income attributable to owners of parent ¥19.2B (EPS 17.87 yen) is 111.9% on paper, meaning dividends exceed Net Income. Free Cash Flow was -¥126.4B and the total shareholder return of ¥49.7B (dividends ¥24.4B + buybacks ¥25.3B) was entirely funded by external financing (short-term borrowings increase ¥150.9B). Total Return Ratio (dividends + buybacks) reaches 258.9%, posing clear sustainability issues. Next-year forecast dividend is ¥10, and against forecast EPS 1.64 yen the implied payout ratio is 610% (mathematically extreme), but given the conservatism of the full-year Net Income forecast ¥2.0B, a ¥10 dividend is reasonable on an actual results basis (Net Income ¥19.2B). Share buybacks ¥25.3B matched prior year ¥25.3B, indicating maintained return intent, but considering negative OCF and large negative FCF, future priority is likely to restore cash generation and reduce leverage, with curbs on dividends and buybacks expected.
Working capital expansion risk: Receivables days 128, inventory days 76 are prolonged, and the gap between OCF -¥1.4B and Net Income ¥19.2B is pronounced. Increases in trade receivables +¥19.3B and inventories +¥18.5B outpaced sales growth +21.9%, suggesting demand forecast uncertainty, sales-mix shifts, and extended collection terms. Without improved working capital efficiency, chronic cash flow deficits and dependency on external financing may become entrenched.
Short-term borrowing dependence and liquidity risk: Short-term borrowings ¥380.9B (79.1% of current liabilities) versus cash ¥140.1B yields a cash/short-term liabilities ratio of 0.37x, indicating significant maturity mismatch. Short-term borrowings increased ¥150.9B YoY, and reliance on short-term funding to cover negative OCF and large investments is entrenched. In a rising-rate environment borrowing costs would increase, and in a downturn refinancing difficulty may materialize; until CIP is commissioned and OCF turns positive, liquidity risk remains elevated.
Exchange and special-item dependence risk: Exchange gains ¥7.1B equal about 129% of Operating Income ¥5.5B, and special gains ¥20.9B account for 65% of profit before tax ¥32.2B. If exchange rate volatility increases, non-operating income will swing materially, and special gains such as gains on sale of investment securities have limited repeatability. Unless the core operating margin of 1.4% improves, loss risk will re-emerge when exchange and special supports dissipate.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 1.4% | -94.2% (-358.4%–8.6%) | +95.6pt |
| Net Margin | 4.8% | -101.5% (-373.7%–5.9%) | +106.3pt |
| Both operating margin and net margin materially exceed the industry median, but this reflects many peers being in large losses; in absolute terms the company remains low-profit. |
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 21.9% | -0.6% (-22.4%–13.3%) | +22.5pt |
| Revenue growth outperforms the industry median by +22.5pt, indicating relatively favorable top-line expansion. |
※Source: Company compilation
Although profit recovery and gross margin improvement are progress, Operating Margin remains low at 1.4% and core profitability is fragile. The high SG&A ratio 73.5% and negative OCF show that revenue gains are not translating into cash. If CIP ¥194.1B (17.8% of total assets) is commissioned, higher depreciation will accompany throughput improvements and may create room for operating margin improvement, but the timing and effectiveness of commissioning are pivotal.
Exchange gains ¥7.1B and special gains ¥20.9B supported Net Income ¥19.2B, indicating limited recurring earning power. Exchange sensitivity is high (exchange gains roughly 129% of Operating Income), so exchange volatility feeds directly into profits. Improving operating-stage margin and clarifying hedging policy are essential to stabilize earnings.
Reliance on short-term borrowings ¥380.9B and large FCF deficit -¥126.4B increase financial risk. Payout ratio 111.9% and Total Return Ratio 258.9% paid for by external financing is unsustainable; the planned dividend cut to ¥10 next year reflects weak cash generation. Until working capital normalizes (receivables +¥19.3B, inventories +¥18.5B) and CIP commissioning leads to OCF turning positive and Debt/EBITDA (16.2x) declines, financial constraints are likely to continue pressuring valuation.
This report is an automated financial analysis generated by AI from XBRL earnings release data. It does not constitute a recommendation to invest in any particular security. Industry benchmarks are reference information compiled by our firm based on publicly disclosed financial statements. Investment decisions are your responsibility; consult a professional as needed.